Idioma:

Heart Xenotransplantation: Historical Background, Experimental Progress, and Clinical Prospects

Murthy, Raghav, MBBS ; Bajona, Pietro, MD ; Bhama, Jay K., MD ; Cooper, David K.C., MD, PhD

The Annals of thoracic surgery, 2016-04, Vol.101 (4), p.1605-1613 [Periódico revisado por pares]

Netherlands: Elsevier Inc

Texto completo disponível

Citações Citado por

Enviar para

Título:
Heart Xenotransplantation: Historical Background, Experimental Progress, and Clinical Prospects
Autor: Murthy, Raghav, MBBS ; Bajona, Pietro, MD ; Bhama, Jay K., MD ; Cooper, David K.C., MD, PhD
Assuntos: Animals ; Cardiothoracic Surgery ; Cohort Studies ; Disease Models, Animal ; Graft Rejection ; Graft Survival ; Heart Failure - surgery ; Heart Transplantation - methods ; Heart Transplantation - trends ; Humans ; Prognosis ; Risk Assessment ; Surgery ; Survival Analysis ; Swine ; Tissue and Organ Procurement ; Transplantation Immunology - physiology ; Transplantation, Heterologous - adverse effects ; Transplantation, Heterologous - methods ; Treatment Outcome
É parte de: The Annals of thoracic surgery, 2016-04, Vol.101 (4), p.1605-1613
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Descrição: If pig hearts could be transplanted successfully into patients with end-stage cardiac failure, the critical shortage of hearts from deceased human donors would be overcome. The several attempts at cardiac xenotransplantation carried out in the 20th century, usually with hearts from nonhuman primates (NHPs), are reviewed, as are the surgical techniques used in experimental heart transplantation in animals. For a number of reasons, the pig has been selected as the potential source of organs for clinical transplantation. The major pathobiological barriers that the pig presents, and progress in overcoming these barriers either by genetic engineering of the pig or by the administration of novel immunosuppressive agents, are described. Currently, non–life-supporting pig heterotopic heart transplantation in NHPs has extended to more than 2 years in 1 case, with life-supporting orthotopic heart transplantation of almost 2 months. Future approaches to resolve the remaining problems and the selection of patients for the initial clinical trials are briefly discussed.
Editor: Netherlands: Elsevier Inc
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 4 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Heart Xenotransplantation: Historical Background, Experimental Progress, and Clinical Prospects

Murthy, Raghav, MBBS ; Bajona, Pietro, MD ; Bhama, Jay K., MD ; Cooper, David K.C., MD, PhD

Netherlands: Elsevier Inc

Buscando em bases de dados remotas. Favor aguardar.